A headache specialist weighs in

If you have frequent migraine headaches — occurring a few days a month or more — you know the toll they can take on your work and quality of life.

So how much of a difference might the new migraine-prevention drug erenumab (AimovigTM), approved by the Food and Drug Administration in May, make for you?


Credit: iStock PeopleImages

Read more…